Skip to main content
Clinical Trials/IRCT20210424051058N1
IRCT20210424051058N1RecruitingPhase 3

Comparison of prophylactic and therapeutic effect of amiodarone in heart surgery patients at risk of atrial fibrillation

Hamedan University of Medical Sciences0 sites200 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • Candidate patients for elective cardiac surgery ASA class 2 & 3
  • Consent to participate in the study
  • Having a sinus rhythm before surgery
  • No history of amiodarone allergy

Exclusion Criteria

  • Recipients of antihypertensive drugs except beta blockers and ACE inhibitors
  • Patients with thyroid, renal, pulmonary, hepatic disorders
  • Rate of less than 50
  • Heart failure
  • Atrioventricular block

Investigators

Similar Trials